Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
HYDERABAD, INDIA: Dr Reddy’s Laboratories, the country second largest pharma company, expects to sign a definitive agreement by June with Japan-based Fujifilm for a joint venture (JV) that will develop and produce generic drugs for the Japanese market. “A definitive agreement is expected to be signed by June. After that it will take 2-3 years before we come out with products. We will have to get product approvals form Japanese authorities before the launch,” said Umang Vohra, Chief Financial Officer, Dr Reddy’s Laboratories (DRL).
DRL had announced the partnership in July, 2011. The new joint venture is said to have 51 per cent stake owned by Fujifilm and 49 per cent stake owned by Dr Reddy’s. The company may set up a manufacturing facility there as part of the JV agreement. “We cannot share the finer details as of now. If required we will set up a facility. It depends on the terms of the agreement,” said Vohra.
According to IMS data, Japan is the world’s second largest pharmaceutical market, estimated to be $97 billion. Low penetration with only about 23 per cent of Japanese prescription drug sales (by volume) contributed by generics as compared to 70 per cent by volume in the US. The Japanese government is actively promoting use of generics to alleviate patients’ expense and reduce national medical expenditure under the goal of “Increasing the market share of generic drugs by sales volume to at least 30 per cent by 2012,” Fujifilm had said when it signed the MoU with DRL.
© PTI News
Login
NEW DELHI, INDIA: HPCL-Mittal Energy (HMEL), a joint venture of state-owned Hindustan Petroleum Corporation and steel czar Lakshmi Mittal, recently an ...
CHENNAI, INDIA: Chemetall, the global metal surface treatment company, has invested in a new production plant in Chennai, India. The new facility will ...
WOODLAND PARK, US: Cytec Industries has firm intention to acquire all of the outstanding shares of Umeco plc, an international provider of advanced co ...
MUMBAI, INDIA: Oil and Natural Gas Corporation (ONGC) Limited, India and ConocoPhillips, US, have signed a Memorandum of Understanding (MoU) for coope ...
GURGAON, INDIA: Ranbaxy Laboratories has commenced exports of Atorvastatin calcium oral tablets to the US market, from its Mohali SEZ manufacturing fa ...
MUMBAI, INDIA: BASF India Limited will invest €150 million to set up a new chemical production site at the Dahej Petroleum, Chemicals and Petroch ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder